Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Rite Aid Pharmacists Offering Free Medicare Part D Consultations Starting Today

Starting today, seniors and their caregiverscan stop by any Rite Aid pharmacy for a free personalized Medicare Part D consultation with a Rite Aid pharmacist or use Rite Aid's dedicated Medicare Advisor comparison tools online at www.riteaid.com. Appointments...

Trophos program boosted by EUR 1 million grant for olesoxime in progressive Multiple Sclerosis

  Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the award of a EUR 1 million grant to support the Translate-MS-Repair...

Lilly, Roche drugs chosen for Alzheimer’s prevention tria

Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms. The experimental medicines...

Recipharm and Astimex Pharma form new development and manufacturing collaboration

Recipharm AB and Astimex Pharma AB have today announced the formation of a collaboration agreement for the development and manufacture of a pharmaceutical product. The formulation development work will take place at the Recipharm...

Cytheris publication in Blood demonstrates CYT107 reverses lymphopenia and increases virus-specific immunity post stem cell transplantation

Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today the publication of a paper demonstrating that Cytheris' CYT107, glycosylated recombinant human interleukin-7 (glycosylated r-h-IL7) can enhance immune T cell recovery after...

GenoLogics Unveils Clarity LIMS for CLIA-Certified Next Generation Sequencing Labs

Bio-IT World Europe Conference – GenoLogics Life Sciences Software, a leading provider of laboratory information management systems (LIMS) designed for today’s omics labs, unveiled Clarity LIMS, a revolutionary LIMS that sets the bar for LIMS in clinical and...

Affimed Therapeutics AG: Affimed Raises Eur 15.5 Million in a Series D Financing Round

Affimed Therapeutics AG, the therapeutic TandAb antibody company, today announced the successful closing of a Series D financing round of EUR 15.5 million. The proceeds from this transaction will be used to fund the clinical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »